CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 711 - 720 of 730
Study Number Lead Group Study Title CIRB Study Status
A231602CD Alliance Assessing Financial Difficulty in Patients with Blood Cancers Cancer Prevention and Control CIRB Available to Open
WF-1804CD NCORP-Wake Forest University Assessing effectiveness and implementation of an EHR tool to assess heart health among survivors (AH-HA) Cancer Prevention and Control CIRB Available to Open
EAQ162CD ECOG-ACRIN Longitudinal Assessment of Financial Burden in Patients with Colon or Rectal Cancer Treated with Curative Intent Cancer Prevention and Control CIRB Available to Open
MDA2016-07-02 CLO-MD Anderson A Randomized, Double-blind, Placebo-controlled Study of 4-hydroxytamoxifen Topical Gel in Women with Mammographically Dense Breast Cancer Prevention and Control CIRB Available to Open
NWU2015-06-04 CLO-Northwestern University Phase IIB trial of neoadjuvant oral tamoxifen versus transdermal 4-hydroxytamoxifen in women with DCIS of the breast Cancer Prevention and Control CIRB Available to Open
EA1141 ECOG-ACRIN Comparison of Abbreviated Breast MRI and Digital Breast Tomosynthesis in Breast Cancer Screening in Women with Dense Breasts Cancer Prevention and Control CIRB Available to Open
A221504 Alliance A Randomized; Double-Blind; Placebo-Controlled Pilot Study of an Oral; Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer (Adenocarcinoma) Cancer Prevention and Control CIRB Available to Open
MDA2013-02-02 CLO-MD Anderson Effect of Aspirin on Biomarkers of Barrett’s Esophagus After Successful Eradication of Barrett’s Esophagus with Radiofrequency Ablation Cancer Prevention and Control CIRB Available to Open
S1501 SWOG Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer; Phase III Cancer Prevention and Control CIRB Available to Open
UWI2015-05-01 CLO-University of Wisconsin Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect Cancer Prevention and Control CIRB Available to Open
Displaying 711 - 720 of 730